Artificial intelligencefromTNW | Deep-Tech3 months agoEurope accelerates AI drug discovery as DeepMind spinoff targets trials this yearIsomorphic Labs aims to start clinical trials for AI-designed drugs by the end of this year.
fromTechCrunch4 weeks agoLondon startupAlphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive | TechCrunchIsomorphic Labs has raised $600 million to enhance its AI drug discovery efforts and support clinical trials.
Artificial intelligencefromTNW | Deep-Tech3 months agoEurope accelerates AI drug discovery as DeepMind spinoff targets trials this yearIsomorphic Labs aims to start clinical trials for AI-designed drugs by the end of this year.
fromTechCrunch4 weeks agoLondon startupAlphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive | TechCrunchIsomorphic Labs has raised $600 million to enhance its AI drug discovery efforts and support clinical trials.
London startupfromNew York Post1 month agoAlphabet's Isomorphic Labs raises $600M in first funding round for AI drug businessIsomorphic Labs raised $600 million to enhance AI-driven drug development, aspiring to revolutionize disease treatment and accelerate medical breakthroughs.
fromTechCrunch3 months agoArtificial intelligenceReid Hoffman's Manas AI raises $24.6M, a fraction of other AI drug discovery startups | TechCrunchManas AI, co-founded by Reid Hoffman, is an AI-driven startup focusing on drug discovery for major cancers, raising $24.6 million in seed funding.